16th International Virtual Conference on Malignant Lymphoma
June 18 - 22, 2021| Join us at this international congress to learn more about the latest advances in the science regarding malignant lymphoma.
- Category:
- Past Events
News & Events
2021 ASCO Virtual Scientific Meeting
June 4 - 8, 2021 | Join us at ASCO and learn about breakthrough research being presented by HTG customers.
- Category:
- Past Events
Nature Research Custom Media webcast: A comparison of gene expression technologies in clinical applications
Dr. Kerry Culm-Merdek of Oncologie and Dr. Marian Navratil of HTG Molecular Diagnostics will describe their cross-platform comparison study between RNA-Seq and HTG’s translational research profiling panel, the HTG EdgeSeq Precision Immuno-Oncology Panel (PIP) for measuring gene expression.
- Category:
- Past Events
AACR Virtual Meeting II Poster Session
EMD Serono’s Dr. O’Rourke, et. al. presents comparison of
HTG EdgeSeq technology
- Category:
- Past Events
ASCO 2020 Virtual Scientific Meeting Poster Session
Platform comparison of HTG EdgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens.
- Category:
- Past Events
LinkedIn Webinar: Virtual Podium 2020, Session 6, Precision Medicine
Listen to HTG’s presentation on New End-User Bioinformatics Pipeline for Patient Stratification in Precision Medicine.
- Category:
- Past Events
LinkedIn Webinar: New end-user bioinformatics pipeline for patient stratification in precision medicine
Virtual Podium presentation by Dr. James Cooley. Register now!
- Category:
- Past Events
USCAP 2020 Customer Presentation by Dr. Leonie AS Frauenfeld
Presentation Background: Diffuse large B-cell lymphoma (DLBCL) is the most common NHL in adults. Gene expression profiling (GEP) divides DLBCL according to the cell of origin (COO) into three subgroups: GCB, ABC and unclassifiable (UNC), exhibiting different mutational profiles.
- Category:
- Past Events
USCAP 2020 Customer Poster by Dr. Michael J. Hwang
Sarcomatoid Renal Cell Carcinoma Demonstrates an Immunosuppressive Tumor Microenvironment – Implication for Therapeutic Benefit in the Immunotherapy Era
Renal cell carcinoma (RCC) with sarcomatoid features (sRCC) is an aggressive form of RCC with poor response to conventional therapies. Immune checkpoint inhibitors have shown promising therapeutic effect for sRCC in recent small series and sRCC has demonstrated higher PD-L1 expression and PD-1 positive tumor-infiltrating lymphocytes compared to high-grade clear cell RCC (ccRCC). Our aim was to use multiplexed gene expression assays to gain a broader view of the underlying tumor microenvironment in sRCC.
- Category:
- Past Events
HTG to speak at the Liquid Biopsy Summit
HTG presentation on the Methods and Challenges of Quantitative miRNA Profiling
- Category:
- Past Events
15th Annual Biomarkers Congress Genomic Markers Congress
Join HTG at the 15th Annual Biomarkers Congress along with our guest speaker, Dr. Megan Lloyd, University of Southampton Academic Unit of Cancer Sciences
- Category:
- Past Events
Page last updated March 20, 2023